Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis

PHASE1CompletedINTERVENTIONAL
Enrollment

1,519

Participants

Timeline

Start Date

June 27, 2014

Primary Completion Date

May 15, 2018

Study Completion Date

May 15, 2018

Conditions
Tinea Pedis
Interventions
DRUG

Naftifine Hydrochloride Gel 2%

Naftifine Hydrochloride Gel 2% applied once daily for fourteen consecutive days to affected areas plus a 1/2 inch margin of healthy surrounding skin.

DRUG

Naftin® Gel 2%

Naftin® Gel 2% applied once daily for fourteen consecutive days to affected areas plus a 1/2 inch margin of healthy surrounding skin.

DRUG

Placebo Topical Gel

Placebo Topical Gel applied once daily for fourteen consecutive days to affected areas plus a 1/2 inch margin of healthy surrounding skin.

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT02335255 - Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis | Biotech Hunter | Biotech Hunter